Avoro Capital Advisors LLC
Institutional investor · Portfolio as of Q3 2020
Top Holdings46 positions
IMMUNOMEDICS INC | 26.3M | $2.2B | 31.7% | — | — | 7 qtrssince 2019-Q1 | Unchanged 0 |
MIRATI THERAPEUTICS INC | 4.3M | $721.2M | 10.2% | — | — | 7 qtrssince 2019-Q1 | Increased 63 |
HORIZON THERAPEUTICS PUB LTD | 7.7M | $594.3M | 8.4% | — | — | 6 qtrssince 2019-Q2 | Increased 77 |
IOVANCE BIOTHERAPEUTICS INC | 9.5M | $313.9M | 4.5% | $12.44 | +159.55% | 7 qtrssince 2019-Q1 | Decreased 0 |
ASCENDIS PHARMA A S | 1.8M | $277.8M | 3.9% | $118.44 | +28.55% | 7 qtrssince 2019-Q1 | Increased 59 |
MYOKARDIA INC | 1.9M | $257M | 3.7% | — | — | 7 qtrssince 2019-Q1 | Increased 57 |
ARGENX SE | 902,500 | $236.9M | 3.4% | $132.04 | +98.82% | 7 qtrssince 2019-Q1 | Decreased 0 |
SAREPTA THERAPEUTICS INC | 1.7M | $235.2M | 3.3% | $118.96 | +18.77% | 7 qtrssince 2019-Q1 | Unchanged 0 |
ARENA PHARMACEUTICALS INC | 3.1M | $231.8M | 3.3% | — | — | 2 qtrssince 2020-Q2 | Increased 92 |
AMICUS THERAPEUTICS INC | 10.9M | $153.2M | 2.2% | $12.98 | +8.46% | 7 qtrssince 2019-Q1 | Decreased 0 |
ACCELERON PHARMA INC | 1.4M | $151.9M | 2.2% | — | — | 3 qtrssince 2020-Q1 | Increased 66 |
BIOMARIN PHARMACEUTICAL INC | 1.8M | $133.1M | 1.9% | $84.82 | -10.40% | 7 qtrssince 2019-Q1 | Decreased 0 |
MERSANA THERAPEUTICS INC | 6.8M | $126.6M | 1.8% | $553.14 | -15.12% | 2 qtrssince 2020-Q2 | Increased 51 |
MADRIGAL PHARMACEUTICALS INC | 890,000 | $105.7M | 1.5% | $120.17 | -1.20% | 7 qtrssince 2019-Q1 | Increased 77 |
DECIPHERA PHARMACEUTICALS IN | 1.8M | $93.4M | 1.3% | — | — | 4 qtrssince 2019-Q4 | Decreased 0 |
ADAPTIMMUNE THERAPEUTICS PLC | 11M | $87.8M | 1.2% | $9.14 | -16.21% | 2 qtrssince 2020-Q2 | Increased 53 |
KARYOPHARM THERAPEUTICS INC | 6M | $87.6M | 1.2% | $171.34 | +33.94% | 5 qtrssince 2019-Q3 | Decreased 0 |
CONSTELLATION PHARMCETICLS I | 4.3M | $86.6M | 1.2% | — | — | 4 qtrssince 2019-Q4 | Increased 51 |
ADVERUM BIOTECHNOLOGIES INC | 8M | $82.4M | 1.2% | $113.91 | -8.26% | 6 qtrssince 2019-Q2 | Increased 51 |
TRILLIUM THERAPEUTICS INC | 5.5M | $78.2M | 1.1% | — | — | 3 qtrssince 2020-Q1 | Increased 55 |
Avoro Capital Advisors LLC manages $7B across 46 positions as of Q3 2020. Top holdings: IMMU (31.7%), MRTX (10.2%), HZNP (8.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2.5/5.0.
Active quarter - 9 new positions, 7 exits, 20 increased. Top move: ARNA (INCREASED, conviction 92). Portfolio: $7.0B across 46 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR